Patents by Inventor Benjamin Arthur Frederick James

Benjamin Arthur Frederick James has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6337386
    Abstract: A toxin assay that uses a substrate for cleavage by the toxin and antibodies that do not recognise the substrate but recognise and bind to the product of cleavage of the substrate by the toxin. The substrate can be a nerve cell peptide when the assay is for botulinum toxin or tetanus toxin.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: January 8, 2002
    Assignee: Microbiological Research Authority
    Inventors: Clifford Charles Shone, Bassam Hallis, Benjamin Arthur Frederick James, Conrad Padraig Quinn
  • Patent number: 6043042
    Abstract: A toxin assay that uses a substrate for cleavage by the toxin and antibodies that do not recognize the substrate but recognize and bind to the product of cleavage of the substrate by the toxin. The substrate can be a nerve cell peptide when the assay is for botulinum toxin or tetanus toxin.
    Type: Grant
    Filed: January 30, 1998
    Date of Patent: March 28, 2000
    Assignee: Microbiobiological Research Authority
    Inventors: Clifford Charles Shone, Bassam Hallis, Benjamin Arthur Frederick James, Conrad Padraig Quinn
  • Patent number: 5962637
    Abstract: A toxin assay that uses a substrate for cleavage by the toxin and antibodies that do not recognise the substrate but recognise and bind to the product of cleavage of the substrate by the toxin. The substrate can be a nerve cell peptide when the assay is for botulinum toxin or tetanus toxin.
    Type: Grant
    Filed: December 3, 1996
    Date of Patent: October 5, 1999
    Assignee: Microbiological Research Authority
    Inventors: Clifford Charles Shone, Bassam Hallis, Benjamin Arthur Frederick James, Conrad Padraig Quinn